N-methyl-4-phenylpyridinium and an endogenously formed analog, N-methylated beta-carbolinium, inhibit striatal tyrosine hydroxylation in freely moving rats.
The effects of N-methyl-4-phenylpyridinium (MPP+) and its endogenous analog, 2,9-di-methyl-norharmanium (2,9-Me2NH+), on in vivo tyrosine hydroxylation were evaluated in freely moving rats. MPP+ gradually but almost completely reduced tyrosine hydroxylation, even at a dose as low as 0.05 mM. This effect was considered to be caused by the inhibition of tyrosine hydroxylase (TH) activation. On the contrary, 1 mM 2,9-Me2NH+ rapidly reduced 3,4-dihydroxyphenylalanine production to 10% of the basal level only during its perfusion, indicating direct inhibition of TH activity. The present study revealed that MPP+ and 2,9-Me2NH+ were taken up into dopaminergic neurons and then inhibited in vivo dopamine synthesis prior to cell death possibly in different manners.